PIHN Plans for Rapid Expansion With New Sales Offices in Florida, Canada and Mexico
09 Abril 2014 - 6:20AM
Marketwired
PIHN Plans for Rapid Expansion With New Sales Offices in Florida,
Canada and Mexico
PLANO, TX--(Marketwired - Apr 9, 2014) - Polaris International
Holdings, Inc. (OTC Pink: PIHN) (PINKSHEETS: PIHN) is excited to
announce its medical division, ProCannas, is opening three new
sales offices in Tampa, FL; Vancouver, British Columbia, Canada;
and Mexico City, Mexico in the Summer of 2014. The Company is
also exploring the possibility of distribution channels in select
areas throughout India and Asia.
The Company has received multiple requests from Physicians in
Tampa and other parts of Florida to begin trials with our
transdermal cannabinoid patch. The Company's sales offices
will assist the Physicians with implementation of the trials using
the Company's proprietary tracking software.
"The Company believes that establishing these sales locations
will provide more efficient customer service to our participating
physicians and be more economically favorable to the Company's
bottom line. Physicians feel more comfortable having a sales
and service person in the area rather than a customer service
representative over the phone," states Medical Director Dr. Vasthi
Alvarez Avila.
ABOUT THE COMPANY
ProCannas' core business focuses on the manufacture and
distribution of new, pharmaceutical grade cannabinoid based
products for medicinal use. Due to the concentrated strength
and unique mix of ingredients integrated within our products, they
are intended to be available to patients only through licensed
participating physicians. Due to recent changes in the law
regarding the medical use of marijuana, coupled with studies and a
strong body of evidence highlighting that THC is not the
significant component for medicinal use, doors are opening for
innovation. Laws are expected to become even more favorable
for companies like ProCannas. The Company intends to target a broad
range of specialties with this novel product, including but not
limited to sports medicine, pain management, neurology, and
osteopathic medicine.
Safe Harbor Statement:
This news release includes
forward-looking statements pertaining to future anticipated
projected plans, performance and developments, intended to qualify
for the safe harbor from liability established by the Private
Securities Litigation Reform Act of 1995. Any statements on this
news release that are not statements of historical fact should be
considered forward-looking statements. These forward-looking
statements generally can be identified by phrases such as
"believes," "expects," "anticipates," "foresees," "forecasts,"
"estimates," "intends," or other words or phrases of similar
import. Similarly, statements in this news release that describe
the Company's business strategy, outlook, objectives, plans,
intentions or goals also are forward-looking statements. All such
forward-looking statements are subject to certain risks and
uncertainties that could cause actual results to differ materially
from those in forward-looking statements.
Investor Inquiries: Polaris International Holdings, Inc.
WWW.Procannas.net Info@Procannas.net
Polaris (CE) (USOTC:PIHN)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Polaris (CE) (USOTC:PIHN)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024